Children and young people whose mothers had a BMI greater than 30 during early pregnancy are at an increased risk
Home »
CN Bio’s PhysioMimix™ adopted by King’s College London to investigate chronic liver disease
CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single and multi-organ microphysiological systems (MPS), today announced that
Review suggests added sugars are contributing to liver disease among children
A review of more than 20 studies by researchers at Arizona State University and the Translational Genomics Research Institute (TGen),
WHA’s president outlines plans to improve treatments for patients with hepatitis
Danjuma Adda, a Nigerian public health expert, became the president-elect of the World Hepatitis Alliance (WHA) in November last year.
Minorities Underrepresented on Liver Transplant Waiting Lists
Non-Hispanic Black and Hispanic patients are underrepresented on many liver transplant waiting lists, whereas non-Hispanic White patients are often overrepresented,
International research network identifies triggers for severe course of liver cirrhosis
Chronic liver disease and even cirrhosis can go unnoticed for a long time because many patients have no symptoms: the
Surprising players in acute liver failure point to potential treatment
Acute liver failure is a devastating, rapidly progressing disease that results in death in 80% of cases, unless an emergency
Premature deaths from alcoholic liver disease rising as gap between men and women narrows
A new study in the American Journal of Preventive Medicine, published by Elsevier, identifies emerging patterns in the rate of
Aerobic exercises could help fatty liver issues: Study
A new study highlights that fitness may be a more important clinical endpoint for improvement in patients with fatty liver
Blood tests can predict the risk of liver cirrhosis
Repeated measurements of the biomarker FIB-4 in the blood every few years can predict the risk of developing severe liver